|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 18 β-glycyrrhetic acid (1) | 2 (2) | 2, 5-diaza bicyclo [4.3.1] compounds (1) |
| 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) | 2-aminobenzothiazole (1) |
| 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) | 25(OH)2D (1) |
| 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) | 32 factorial design (1) |
| 3D QSAR (1) | 3D-QSAR (1) | 3’ UTR region (1) |
| 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) | 4-pyridinecarboxylic acid hydrazide (1) |
| 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) | 5-Fluorouracil (1) |
| 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) | 6 (1) |
| 6-Mercaptopurine (1) | 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) |
| 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | A. nilotica (1) |
| ABC analysis (4) | ABC-VED matrix (4) | Abdominal Pregnancy (1) |
| Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
| ABTS (1) | Abuse (1) | Academic Stressors scale (1) |
| Accuracy. (1) | Accurate (1) | ACE (2) |
| ACE inhibitor (1) | Aceclofenac (1) | Acetazolamide (1) |
| acetic acid induced writhing test (1) | Acetyl cholinesterase estimation (1) | Acetyl isoniazid (1) |
| Acetylation rate (1) | Acetylcholinesterase (1) | Acetylcholinesterase inhibitors (1) |
| ACF (1) | Acid hydrolysis (1) | Acid violet 43 (1) |
| Acid-resistant capsules (1) | Acne (1) | Acne vulgaris (1) |
| Aconitine (1) | Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) |
| Actinomycetes (1) | Activator procaspase-3 (1) | active pharmaceutical ingredient (1) |
| Active site (1) | Activities of daily living (ADL) scale (1) | Acupuncture (1) |
| Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) | Acute Inflammation (1) |
| Acute inß ammation (1) | Acute poisoning (1) | Acute ST segment elevation myocardial infarction (1) |
| Acute toxicity (1) | acyclovir (2) | Adenanthera (1) |
| Adenosine A 2A antagonist (1) | Adherence (5) | Adherence. (1) |
| Adiantum venustum (1) | ADME properties. (1) | ADR (2) |
| ADR management (1) | ADR monitoring centre (AMC). (1) | ADRs (2) |
| Adsorbent (1) | adverse drug events (1) | Adverse drug reaction (8) |
| Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse drug reaction. (1) |
| Adverse Drug Reactions (8) | Adverse drug reactions (ADRs) (1) | Adverse event following immunization (AEFI) (1) |
| Adverse events (1) | Adverse reaction (1) | Aedes aegypti (2) |
| Aerobic exercise (1) | Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) |
| Age (2) | Ageratum conyzoides L (1) | air pollution (1) |
| Airjet (1) | Albendazole (1) | Albino mice (1) |
| Albino wistar rats (1) | Alcohol (2) | alcoholic extract (1) |
| ALDEN (1) | Aldose reductase inhibitors (1) | allantoin (1) |
| Allergic rhinitis (1) | Allergy (3) | Alloxan (1) |
| Alloxan monohydrate (1) | Alocasia indica Schott (1) | Aloe vera (1) |
| Alpha-adrenoceptor (1) | alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) |
| Alprazolam (1) | Alteration of drug cost (1) | Altered Mental Status (AMS) (1) |
| alternative therapy (1) | Alzheimer's disease (1) | Alzheimers disease (1) |
| Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) | Amber (1) |
| Ambroxol hydrochloride (1) | Amides (1) | Amikacin Sulfate (1) |
| Amino acids (1) | amino benzylated Mannich bases (1) | amivudine (1) |
| Amlodipine (2) | Amlodipine besylate (2) | Ammonium salts (1) |
| Amoora cucullata. (1) | amoxicillin (1) | Amoxicillin sodium (1) |
| Amrita School of Pharmacy (1) | Amrita Vishwa Vidyapeetham (1) | Anabolic. (1) |
| Analgesia (1) | analgesic (8) | Analgesic effect (1) |
| analgesic- anti-inß ammatory activity (1) | Analgesics (1) | Analysis in capsules (1) |
| Analysis of variance (1) | Anaphylactic shock (1) | Anaphylaxis. (1) |
| and TGF–β (1) | Andragogy (1) | Anemia (1) |
| Anethum graveolens (1) | Angiogenic growth factors (1) | antepartum (1) |
| anthelmintic (1) | anthelmintic property (1) | Anthocyanin (1) |
| Anthracyclines (1) | Anti aging (1) | Anti hyperglycemic (1) |
| Anti inflammatory (1) | anti-anxiety activity (1) | Anti-asthmatic activity (1) |
| Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) | Anti-diabetic drugs (1) |
| Anti-epileptic drugs utilization (1) | Anti-HIV (1) | anti-hypertensive agent (1) |
| Anti-infective (2) | Anti-infective agents (1) | anti-inflammation (1) |
| anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) | anti-inflammatory activity (2) |
| anti-inflammatory activity', (1) | anti-inflammatory agent (1) | anti-inß ammatory (3) |
| Anti-inß ammatory activity (1) | Anti-obesity (1) | Anti-oxidant (2) |
| Anti-parkinsonism activity (1) | anti-spasmodic drug (1) | Anti-tumor agent (1) |
| antiamnesic agents (1) | Antianxiety (1) | antibacterial (3) |
| antibacterial activity (4) | Antibacterial drugs (1) | Antibiotic (2) |
| antibiotic guidelines (1) | Antibiotic Resistance (2) | Antibiotics. (1) |
| Anticancer (4) | Anticancer activity (1) | Anticancer drugs (1) |
| Anticholinergic (1) | Anticoagulant (1) | Anticoagulant service (1) |
| anticonvulsant activity (1) | anticonvulsants (1) | Anticovulsant (1) |
| Antidepressants (1) | Antidiabetic (2) | Antidiabetic activity (2) |
| Antidiabetic agents (1) | antiepileptic agents (1) | Antiepileptic Drugs (2) |
| antifungal (1) | antifungal activity (1) | Antigen (1) |
| antigen protein (1) | Antihistaminic (2) | Antihyperglycemic (1) |
| Antihypertensive (1) | Antihypertensives (1) | Antiinflamatory (1) |
| Antimalarial (2) | Antimicrobial (4) | Antimicrobial activities (1) |
| Antimicrobial activity (6) | Antimicrobial agent (1) | Antimicrobial efficacy (1) |
| Antimicrobial resistance (1) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) | Antimicrobial Stewardship (1) |
| Antimicrobials (4) | Antimosquito (1) | Antimycotic Activity (1) |
| antinociceptive (1) | Antioxidant (19) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) |
| Antioxidant activity (6) | antioxidant effect (1) | Antioxidant properties (1) |
| Antioxidants (6) | Antipsychotics (1) | antipyretic (2) |
| Antiretroviral drugs (1) | Antiretroviral therapy (2) | Antispasmodic (1) |
| Antithrombotic (2) | Antithyroid drugs (1) | Antitubercular (1) |
| Antitubercular drugs. (1) | antiulcer (1) | Antivenom (1) |
| Antivenom reactions (1) | Antiviral (1) | antiviral activity (1) |
| Antiviral RNA (1) | Anxiety (2) | APAP (1) |
| APC (1) | Apoptosis (1) | Application (1) |
| Application to PK profile studies (1) | applications (1) | Appropriateness (1) |
| Aqueous extract (3) | AR Caps (1) | Arabic gum (1) |
| ARDS (1) | Area above the blood glucose levels-time curve. (1) | area of wound healing (1) |
| Areca nut (1) | Arginase (2) | Arginine (1) |
| Armodafinil (1) | ART (1) | Artemia salina (1) |
| Artemia salina. (1) | Artemisia absinthium (1) | Artemisia macrocephala (1) |
| arterial hypertension (1) | Arteriovenous malformation (AVM) (1) | Arthritis (1) |
| ARV Drugs (1) | Ascorbic acid (3) | Asenapine (1) |
| asian developing nations (1) | Asiaticoside (1) | Aspergillus niger (2) |
| Aspergillus niger. (1) | Aspergillus terreus (1) | Aspirin (1) |
| Assay (2) | Asthma (4) | Asymptomatic neurocognitive impairment (1) |
| Ataxia (1) | ATC/DDD (3) | Atherosclerotic Vascular Disease (1) |
| Atorvastatin (5) | Atorvastatin calcium (1) | Atorvastatin. (1) |
| ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) | Atrial fibrillation (1) |
| Atropine (1) | Attitude (6) | Attitude and practice (1) |
| Attitude. (1) | Aucubin (1) | Authors (1) |
| Authorship issues (1) | Autism spectrum disorders (1) | Auto antibody (1) |
| Auto medication (1) | Autoimmune disorders (1) | Autoimmunity (1) |
| Averrhoa bilimbi (1) | Avicel (1) | Awareness (2) |
| Ayurveda (1) | Azelaic acid (1) | Azilsartan medoxomil (1) |
| B cell epitope (1) | Bacoside A3 (1) | Bacterial isolates (1) |
| Bacteriological culture (1) | Bacteriostatic (1) | Bamboo betung (1) |
| Banana (1) | Bangladesh (2) | bark (1) |
| Barleria cristata (1) | Barriers (1) | Bauhinia racemosa (1) |
| Bauhinia variegata (2) | Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) |
| BCG vaccine (1) | BCS-IV drug (1) | Beauty Salon Owner (1) |
| Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) | Bedaquiline (1) |
| Belief (1) | Benchmarking (1) | Benzimidazole derivative (1) |
| benzimidazoles (2) | Benzodiazepines (1) | Benzothiazole analogues (1) |
| Berberis integerrima Bunge (1) | Bibliometrics (3) | Bioactive Metabolites (1) |
| Bioadhesive (1) | Bioanalytical method (1) | Bioanalytical method development (1) |
| Bioassay (1) | bioavailability (5) | Biodegradable (1) |
| Bioethics (1) | Biohazard (1) | Biologics (1) |
| Biology (1) | Biomedical (1) | Bioprospecting. (1) |
| Biopsy Proven Acute Rejection (1) | Biosafety (1) | Biosafety Engineering Control (1) |
| Biotechnology (1) | Bitter (1) | Black tea extract (1) |
| Bleaching (1) | Bleeding time (1) | Bleomycin (1) |
| Blonanserin (1) | Blood brain barrier (1) | Blood glucose (1) |
| Blood pressure (3) | Body Mass Index (1) | Boerhaavia Diffusa (1) |
| Bone (1) | Book Review (1) | Borg scale (1) |
| botulinum toxin (1) | Box-Behnken (1) | Brahmi vati (1) |
| Brain (1) | brand name drugs (1) | Branded medication (1) |
| Bratton-Marshall reagent (1) | Brazil (1) | Breast cancer (5) |
| Brewer’s yeast (1) | Brief COPE scale (1) | Brief medication questionnaire (1) |
| Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) |
| Bromelain (1) | Bromeliaceae (1) | Bromocresol purple (1) |
| Bronchial Asthma (1) | Bryonia laciniosa (1) | Buccal (1) |
| Buccal Patches (1) | budget forecasting (1) | Bufadienolide (1) |
| Bullous eruption (1) | bungarotoxin (1) | Bungarus caeruleus (1) |
| Bungur (1) | Buoyant microspheres (1) | Burden Of Disease (1) |
| Business method (1) | Business model (1) | Butea monosperma (1) |
| C934 (1) | Ca2+ channels (1) | Cadmium chloride (1) |
| Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) |
| Calcineurin inhibitor (1) | Calcium (1) | Calcium channel blocking (1) |
| calcium channel blocking activity (1) | Calcium oxalate (1) | Calcium silicate (1) |
| Calendula officinalis (1) | calendula oil (1) | Camelia sinensis extract (1) |
| Camellia sinensis (1) | Camptothecin (1) | Cancer (4) |
| Cancer Chemotherapy (2) | Cancer treatment (1) | Candida (1) |
| Candida albicans (3) | Candida albicans. (1) | Capacity (1) |
| Capsule (1) | capsules (1) | carbamazepin (1) |
| Carbamazepine (2) | carbohydrazide (1) | Carbomyl Linkage (1) |
| carbon tetrachloride (1) | carbonyl compounds (1) | Carbopol 940 (1) |
| Carcinoma. (1) | cardiac arrhythmias (1) | Cardiac remodeling (1) |
| Cardiology (1) | Cardioprotection (1) | Cardioprotective (1) |
| Cardiotoxicity (2) | Cardiovascular disease (1) | Carnauba wax (1) |
| carrageenan (2) | Caryocar coriaceum (1) | Case report (1) |
| Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) | catalepsy (2) |
| Cation-pi (1) | CationicGuargum (1) | Causality assessment (2) |
| Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | Cefixime (1) |
| ceftriaxone and co-amoxiclav (1) | Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) |
| Cellulase (1) | Cellulite (1) | Cellulitis (1) |
| Cellulose (2) | Cemented (1) | Cementless (1) |
| CEN (1) | Centella asiatica (3) | Central composite design (4) |
| Central post-stroke pain (1) | Cephalexin (2) | Cerebrovascular Accident (1) |
| Cervical dentine hypersensitivity (1) | CFFF (1) | chalcone (1) |
| chalcones (1) | Characterization (4) | Chemical stability (1) |
| Chemomechanical removal (1) | Chemometrics (2) | Chemotherapy (5) |
| Chewing gum (1) | Child Care (1) | Children (2) |
| Children Dentistry (1) | Chitin (1) | Chitosan (6) |
| Chitosan Acetate. (1) | chitosan microspheres (1) | Chitosan nanoparticle (1) |
| Chitosan-g-HPβCD (1) | Chlamydomonas reinhardtii (1) | Chloramphenicol (1) |
| Chlorhexidine (2) | Chlorohexidine (1) | cholesterol (1) |
| Cholesterol HDL (1) | Cholinesterase inhibitors (1) | Chromotropic acid reagent (1) |
| Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) |
| Cigarette smoke (1) | Cilostazol (1) | Cinnamaldehyde (1) |
| Cinnamic acid derivatives (1) | Cinnamomum cassia (1) | Ciprofloxacin (1) |
| Citronella (1) | Citrus hystrix (1) | Citrus limon (2) |
| CKD (1) | CKMB. (1) | Claims (1) |
| Clarithromycin (1) | Classification (1) | Cleistanthin A (2) |
| cleistanthin B (2) | Cleistanthus Collinus (1) | Clinical attachment level (1) |
| Clinical efficacy (1) | Clinical equivalence (1) | Clinical manifestation (1) |
| Clinical Pharmacist (1) | Clinical pharmacist care (1) | Clinical pharmacology (1) |
| Clinical research (1) | Clinical trial (1) | Clinical trials (1) |
| Clinicians (1) | clonidine (2) | Clopidogrel (1) |
| Closed melt (1) | Clove (1) | cloxacillin (1) |
| Cluster analysis (1) | CME (1) | Co-crystal (1) |
| Co-Morbidity (1) | Co-morbidity. Correspondence (1) | co-precipitation method (1) |
| Co-surfactant (1) | Cochlopermum tinctorium (1) | coding system (1) |
| Cognition (2) | Cogrinding (1) | Colloidal carriers (1) |
| Colloidal silicone dioxide (1) | Colon targeted delivery (1) | Colon targeted drug delivery. (1) |
| Colonic delivery (1) | colorimetric assay (1) | Combination tablet (1) |
| Combination Therapy (1) | Combinatorial effect (1) | Comet assay (1) |
| common cold (1) | common cold and cough (1) | Common warts (1) |
| Community Pharmacies (1) | Community pharmacist (1) | Community pharmacy (1) |
| Comorbidity (1) | comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) |
| compensation (1) | Complementary and alternative medicine (2) | complementary and alternative medicines (1) |
| Complementary and alternative therapy (1) | complete epithelization (1) | Compliance (1) |
| compound 48/80 (2) | compritol 888 ATO (1) | Computer (1) |
| Computer literacy (1) | computer-aided instructions (1) | Computer-aided learning (1) |
| Computerized screening systems (1) | CoMSIA (1) | Constipation (1) |
| Consumer (1) | Consumer perception (1) | Content validation (1) |
| content validity (1) | continuing education (1) | Contract research (1) |
| Contract research organizations (1) | Controlled release (4) | convolution (1) |
| convulsions (1) | cooperative practice (1) | COPD (2) |
| Coprocessed excipient (1) | Cordia obliqua (1) | Corneal opacities (1) |
| Coronally advanced flap (1) | Correlation (2) | Corticosteroid (2) |
| Corticosteroids (1) | Cosmetic (2) | Cost avoidance (1) |
| Cost of illness (2) | Cost saving (1) | Cost-effectiveness analysis (1) |
| Cost. (1) | Costing Analysis. (1) | Cotton oil (1) |
| cotton pellet (1) | Cough (1) | Cough medicine (1) |
| cough. (1) | Counterfeit Pharmaceutical Products (1) | Cramer’s Matrix method (1) |
| CRC (1) | Cream (1) | creatinine (1) |
| Critical Care Unit (CCU) (1) | Critical Thinking (1) | cromolyn sodium (1) |
| Croscarmellose sodium (CCS) (1) | Crospovidone (1) | Crospovidone (CP) (1) |
| Cross carmellose sodium (1) | cross-linking agents (1) | Crossandra (1) |
| Croton zehntneri (2) | Crystallinity (2) | CTCAE (1) |
| CTEPH (1) | Cucumis metuliferus (1) | Cucumis sativus (1) |
| CUMIN. (1) | Cuminosides (1) | Curcuma longa (1) |
| Curcumin (2) | current indian scenario of drug interactions (1) | curriculum development (1) |
| Cutaneous Adverse Drug Reactions (CADRs) (1) | CXCR4 (1) | Cyclooxygenase (1) |
| cyclophosphamide (1) | Cymbopogon citratus (1) | Cynodon dactylon (2) |
| CYP genes ; South Indian population ; polymorphisms (1) | Cyst (1) | Cytochrome P 2C9 (1) |
| Cytotoxic (1) | Cytotoxic activity. (1) | Cytotoxic agents (1) |
| Cytotoxicity (2) | CZE (1) | D&C (1) |
| D-optimal design (1) | Daily Defined Dose (1) | Dapsone (1) |
| Data mining algorithms (1) | DDX3 (1) | Death Receptors (1) |
| Decision making (1) | Deep vein thrombosis (1) | deferasirox (1) |
| deferiprone (1) | Deficiency (1) | Degradation (1) |
| Degradation studies (1) | Dehydrozingerone (1) | Delignification (1) |
| Delirium (2) | democratic government (1) | Dengue high fever (1) |
| Dental caries (3) | Dental Caries. (1) | dental management (1) |
| Dental prosthesis. (1) | Dental Students (1) | dentistry. (1) |
| Deodorants (1) | Department of Pharmacy Practice (1) | Dependence (1) |
| Depigmentant (1) | Depok Primary Health Care (1) | Deprescribing (1) |
| Depression (3) | Dermatology life Quality Index (1) | Design of experiments. (1) |
| desirability function (1) | Desirability index. (1) | Desmodium gangeticum (1) |
| Detorsion (1) | Deuterium (1) | device safety (1) |
| dexamethasone (2) | Dexibuprofen (1) | Dextrin (1) |
| Diabetes (4) | diabetes and diabetic vascular complications (1) | Diabetes mellitus (11) |
| diabetes mellitus, (1) | Diabetes Type-II (1) | Diabetes, glucose (1) |
| diabetic dyslipidemia (1) | Diabetic nephropathy (1) | Diabetic retinopathy (1) |
| Diabetic Wound (1) | Diacerein (1) | DiaKure (1) |
| diclofenac (1) | Diclofenac SLN (1) | Diclofenac sodium (1) |
| Dicots (1) | Dicyclomine (1) | differential scanning calorimetry (1) |
| diffuse transmittance (1) | Dillenia indica (2) | Dilleniaceae (1) |
| Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) |
| Dip coating (1) | Diplotropis ferruginea (1) | direct compression (3) |
| Direct to consumer advertising (1) | Discharge against medical advice (DAMA) (1) | discharge orders (1) |
| Discrepancies (1) | Discriminant analysis (1) | Disease (1) |
| disintegration (1) | disintegration time (1) | Disproportionality Analysis (1) |
| Dissolution (4) | dissolution enhancement (1) | Dissolution rate (1) |
| Diuretic (1) | Diuretic activity (2) | DMAIC (1) |
| DMH (1) | DNA damage (1) | DNA fragmentation (1) |
| docking (3) | docking. (1) | Doctor (1) |
| Documentation and records (1) | Donepezil hydrochloride (1) | Dopamine (1) |
| Dosage formulation (1) | Dosage regimen (1) | Dose-dependent (1) |
| DOTS plus (1) | Doxorubicin (2) | Doxorubicin; FRAP assay (1) |
| Doxycycline (1) | DPPH Assay (1) | DPPH scavenging (1) |
| DRcaps (1) | DREEM. (1) | Dried blood spot. (1) |
| Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) | Drug (2) |
| Drug delivery denture (1) | Drug detailing (1) | drug disposal (1) |
| Drug Hypersensitivity (1) | Drug induced nephrotoxicity (1) | Drug Information and Literature Evaluation (1) |
| drug interaction (2) | Drug interaction (DI) (1) | drug interaction management (1) |
| drug interactions (2) | Drug prescriptions (1) | Drug product (1) |
| Drug Related Problems (4) | Drug related side effects (1) | drug release (1) |
| Drug Resistance (1) | Drug risk ratio (1) | Drug safety (2) |
| Drug Safety. (1) | Drug therapy (1) | Drug utilization (2) |
| drug utilization study (1) | Drug utilization. (1) | drug-drug interactions (4) |
| Drug-SLS tablets. (1) | Drugedrug interaction (1) | Drugs (2) |
| drug–drug gliclazide (1) | Drug–drug interaction (1) | Dry extract cinnamon (1) |
| DSPC (1) | Dual Therapy (1) | dual-target-directed drugs (1) |
| Dunaliella salina (1) | Dynamic (1) | Dyslipidemias (1) |
| Dysphagia (1) | e-prescribing (1) | E. coli (1) |
| E.crispa (1) | Early-Related Complications (1) | EC50 values (1) |
| Economic (1) | Economic burden (1) | Edaravone (1) |
| Eddy’s hot plate method. (1) | edema (1) | Editorial (24) |
| Education (2) | Educational excellence (1) | efavirenz (2) |
| Efficacy. (1) | EGCG (1) | Egfr (1) |
| egg albumin microspheres (1) | Elderly (1) | Elderly Patients (1) |
| Electrochemical (1) | electrolyte release (1) | electrolytes (1) |
| Electronic prescribing (1) | Electronic prescription (1) | Electroporation (1) |
| Elevated plus maze (1) | elevated plus maze model (1) | Elisa (1) |
| Emblica offi cinalis (1) | Emergency contraception (1) | Emodin (1) |
| Emotional (1) | Emulgel (1) | Emulsification and Solvent Evaporation (1) |
| emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) |
| Endocrine disruptor (1) | Endophytes (1) | Endothelial cells (1) |
| endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) | Endothelium. (1) |
| Enicostemma littorale (1) | Entire plant (1) | Entrapment afficiency (1) |
| entrapment efficiency (2) | Envenoming (1) | Environmental Factors (1) |
| Enzymatic hydrolysis (1) | eosinophil (1) | Epigallocatechin Gallate (2) |
| Epigallocatechin gallate (EGCG) (1) | Epigenetics (1) | epilepsy (4) |
| erbal drugs (1) | erice declaration (1) | Erythema (1) |
| Erythrina indica (1) | Erythrina variegata (1) | erythropoietin (1) |
| Escherichia coli (1) | Escitalopram oxalate (1) | esomeprazole (1) |
| Essential hypertension (2) | Essential medicine (1) | essential medicines (1) |
| essential oil (4) | essential oil composition (1) | Essential principles (1) |
| Estimated Glomerular Filtration Rate (1) | Estrogen receptor alpha (1) | Ethanol (1) |
| Ethanol extract (1) | ethanolic extracts (1) | Ethiopia (2) |
| ethnicity (2) | Ethnomedicine (1) | Ethosomes (1) |
| Ethyl - 4- acetamido phenoxy acetate (1) | Ethyl acetate (1) | Ethyl acetate fraction (1) |
| ethyl cellulose (2) | ethylcellulose (3) | ethylene glycol (2) |
| Eucalyptus (1) | Eucalyptus hybrid (1) | Eucalyptus oil (2) |
| eudragit (1) | Eudragit RL 100 (1) | eudragit S100 (2) |
| Eudragit-L100 (1) | Eudragit® S100 (1) | Eugenol (1) |
| Euphorbia hirta leaves (1) | Eurycoma Longifolia Jack (1) | ex-vivo performance (1) |
| Ex-vivo permeation (1) | Ex-vivo study (1) | Excision wound model (1) |
| experiences (1) | Experimental ischemic stroke (1) | Exports (1) |
| Expression profile (1) | Extract (1) | Extrapyramidal side-effects (1) |
| extrinsic stains (1) | extrusion (1) | Ezetimibe (2) |
| Fabaceae (2) | factorial design (5) | Factors associated with medication non-adherence (1) |
| Falcipain-2 (1) | Family Planning Services (1) | Family satisfaction (1) |
| family therapy (1) | famotidine (2) | fast disintegrating tablet (1) |
| Fast Disintegrating Tablets. (1) | Fast dissolving films (1) | Fast dissolving tablets (1) |
| Fasting serum insulin level (1) | Fat (1) | Fatty acid profile (1) |
| FC reagent (1) | FDA AERS Database (1) | FDA Approval (1) |
| Fenugreek (1) | Ferritin (1) | Ferrous sulfate (1) |
| Fialuridine', (1) | Ficus bengalensis (1) | Ficus bengalensis (Moraceae) (1) |
| Ficus racemosa (1) | film (1) | film hydration (1) |
| First permanent molars (1) | Fixed drug eruption (1) | Flavonoid (3) |
| Flavonoid Compounds (1) | Flavonoid fraction (1) | flavonoids (2) |
| Flavoxate HCl (1) | FlK-1 (1) | Floating beads (1) |
| floating controlled drug-delivery system (1) | Floating drug delivery system (1) | floating lag time (1) |
| fluoroquinoes (1) | Fluoxetine (1) | Flupritine maleate (1) |
| flurbiprofen (1) | Flux (1) | folkloric use (1) |
| Food drug and cosmetic act (1) | Forced degradation (3) | Forced degradation studies (1) |
| forced swim test (1) | Formulary (1) | Formulary. (1) |
| Formulation (2) | Formulation and development (1) | Fourier transform infra red spectroscopic (1) |
| FPG (1) | FPGEE (1) | Fraction (1) |
| Franz Diffusion Cell (3) | free radical scavenger (1) | Free radicals. (1) |
| Freeze-drying (1) | Freund’s complete adjuvant (1) | Fructo-Oligosaccharide (FOS) (1) |
| Frusemide (1) | Frusemide-induced complications (1) | FTIR (4) |
| Fumes (1) | furosemide (1) | Galacto-Oligosaccharide (GOS) (1) |
| Galic Acid (1) | gallic acid (2) | Gamma irradiation (1) |
| Gangrenous (1) | Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) |
| Garcinia daedalanthera extract (1) | Garcinia imberti bourd (1) | Garcinia indica (1) |
| Garcinia latissima (1) | gaseous contact (1) | gastric treatment (1) |
| Gastric ulcer (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
| gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
| GC-MS (1) | GC-MS analysis (2) | GC-MS. (1) |
| Gelatin (1) | Gelling Capacity. (1) | Gels (1) |
| gemfibrozil (1) | Gender (1) | Gender and HIV. (1) |
| Gene silencing (1) | General medicine (1) | Generic (2) |
| generic drugs (1) | Generic medicines (2) | Generic name. (1) |
| Generic substitution (1) | Generics (1) | Genetic polymorphisms (1) |
| genetic Signature (1) | Genotype frequency (1) | Gentamicin (4) |
| gentamicin sulfate (2) | Geriatrics (3) | GFAP (1) |
| Gibb’s reagent (1) | Ginger (1) | Gingival hyperplasia (1) |
| Gingival hypertrophy (1) | gingival pocket (1) | Gingival recession (1) |
| Gingival thickness (1) | glibenclamide (4) | gliclazide (2) |
| Glimepiride (2) | glimepride (1) | Glipizide (3) |
| glitazars (1) | Global education (1) | Glomerulonephritis (1) |
| Glucagon (1) | Glucocorticoids (1) | Glucose (1) |
| glucose tolerance test (1) | glutathione (1) | Glycerine (1) |
| Glycine max (1) | Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) |
| Gnetum gnemon (2) | Goal orientation (1) | Goldenhar syndrome (1) |
| good manufacturing practices (1) | Gotu kola leaves extract (1) | GPx (1) |
| Graft Survival (1) | Grafting (1) | Gram negative (1) |
| Gram positive (1) | Grape seed extract (1) | Grape seed oil (1) |
| Grapes seed extract (1) | Gravimetry (1) | Grazing angle X-ray diffraction (1) |
| Green tea (1) | Green Tea Leaves Extract (2) | Griseofulvin (1) |
| GSH (1) | guanyl cyclase stimulator (1) | Guest Editorial (1) |
| Guidelines (1) | Gulf cooperation council (1) | Gum and fat fractions (1) |
| Gum arab (1) | Gymnema Sylvestre (2) | GYTS (1) |
| H+ (1) | H-460 (1) | H2 Receptor Antagonist (1) |
| H2O2 (1) | HAART (1) | Haematological (1) |
| Haemolytic ratio. (1) | Hair dye. (1) | Hair Growth Activity (1) |
| Hair Tonic (1) | Hajj (1) | haloperidol (1) |
| Hand and Foot Syndrome (1) | hardness (1) | harmacotherapy-based problems (1) |
| Harmonization (2) | Hazardous drugs (1) | HbA1C (2) |
| HBV (1) | HCT: Hydrocholrothiazide. (1) | HDAC4 (1) |
| HDAC7 (1) | head twitch (1) | Health benefits (1) |
| Health care profession (1) | health care professionals (1) | health care students (1) |
| Health care. (1) | Health Hazard (1) | Health informatics (1) |
| Health Information Technology (1) | Health problems (1) | Health Services Accessibility (1) |
| Healthcare (4) | healthcare communication (1) | Healthcare Delivery (1) |
| healthcare expenditure (1) | Healthcare Professionals (1) | healthcare providers (1) |
| Healthy volunteers (1) | heart failure (2) | Hematological parameters (1) |
| hematological toxicity (1) | Hematology (2) | Hematoma (1) |
| hepatic impairment (1) | Hepatitis (1) | Hepatitis B (1) |
| Hepatitis B virus core protein (1) | Hepatocellular (1) | Hepatocurative (1) |
| hepatoprotective (2) | hepatoprotective activity (3) | Hepatotoxicity (1) |
| HER1 (1) | HER2 (1) | HER3 (1) |
| HER4 (1) | Herbal active ingredients (1) | Herbal drugs (1) |
| Herbal medications (1) | Herbal medicine (2) | herbal medicines (1) |
| Herbal therapy (1) | Herbaldb (1) | HET-CAM (1) |
| Heterocyclic compound (1) | Heterotopic Pregnancy (1) | Hex (1) |
| Hexane (1) | Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) |
| High fat diet (1) | High Fat Diet Model (1) | High impact resin (1) |
| high performance liquid chromatography (1) | high performance thin layer chromatography (1) | High-density lipoprotein cholesterol (1) |
| High-fat diet (1) | high-performance liquid chromatography (2) | High-throughput screening (1) |
| Higher education (1) | highly active antiretroviral therapy (1) | Highly Cited Papers (1) |
| Himatanthus drasticus (1) | Hip Arthroplasty (1) | Hirsutism (2) |
| Histocompatibility. (1) | Histological studies. (1) | Histopathology (2) |
| HIV (1) | HIV associated dementia. (1) | HIV-1 RT (1) |
| HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) | HL-60 and K-562 (1) |
| HMG-CoA Reductase (1) | homology modeling (1) | Honey (1) |
| Honeycomb (1) | Hordeum vulgare (1) | Hordeum vulgare hull (1) |
| Hospital pharmacy (2) | hospitalized children (1) | hospitalized patients (1) |
| Hospitals (1) | host (1) | hot plate (1) |
| HP-ß Cyclodextrin complexes (1) | HPLC (8) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) |
| HPLC method validation (1) | HPLC. (1) | HPMC (1) |
| HPMC capsules (1) | HPMC K100M (1) | HPMC K4M (1) |
| HPTLC (5) | HRQoL (2) | HSV-1 (1) |
| Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (3) |
| human immunodeÞ ciency virus (1) | Human Papillomavirus (1) | Human plasma (2) |
| human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) |
| Hydnocarpus Pentandra (1) | Hydralazine hydrochloride (1) | Hydroalcoholic (1) |
| hydrochlorothiazide (1) | Hydrochlorthiazide (1) | hydrogel (2) |
| Hydrogels (1) | hydrogen sulfide (1) | hydrogenated castor oil (1) |
| Hydrophilic drugs (1) | Hydrophillic sealants (1) | Hydrophobic sealants (1) |
| hydroxy propyl methyl cellulose (1) | Hydroxyl radical (1) | hydroxypropyl cellulose (1) |
| hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (1) | Hydroxypropyl methylcellulose E15 (1) |
| Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
| Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
| Hyperglycemia (1) | Hyperglycemic (3) | Hyperglycemic mice (1) |
| Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
| hypertension (5) | Hypertension( HTN) (1) | Hypertensive’s (1) |
| Hyperthyroidism (1) | hypertriglyceridemia (2) | Hypertrophy (1) |
| Hyperzincuria (1) | Hyphenated system (1) | hypoglycemic (1) |
| Hypoglycemic activity (1) | hypolipidemic (1) | Hypothyroidism (1) |
| Hypozincaemia (1) | IBD - Inflammatory Bowel Disease (1) | IC50 (2) |
| ICH (2) | ICH guidelines (2) | ICP22 (US1) gene (1) |
| IL-17 (1) | IL-6 (2) | IL-MAE (2) |
| Illiterate (1) | Iloperidone (1) | image analysis (1) |
| imidazole (1) | Immune response (1) | immunocytochemistry (1) |
| Immunoinformatics (1) | Immunological response (1) | In silico (2) |
| in situ gelation (1) | in vitro (4) | In vitro kinetics (1) |
| In vitro penetration lotion (1) | In vitro penetration test (1) | In vitro Penetration Test. (1) |
| In vitro release (1) | In vitro–In vivo (1) | in vivo (1) |
| In vivo kinetics (1) | In-patien (1) | in-vitro dissolution study (1) |
| In-vitro skin permeation (1) | inclusion complexes (2) | indexed cost (1) |
| India (7) | India. (2) | Indian context (1) |
| Indian Traditional medicine (1) | Indion 234 (2) | Indion resin (1) |
| indomethacin (2) | Indonesia (1) | Indonesian Herbal Database. (1) |
| Indonesian National Health Insurance (1) | Industry (1) | Inequality (1) |
| infarct size (1) | infective endocarditis (1) | infertility (1) |
| inflammation (3) | inflammatory bowel disease (2) | Information need (1) |
| Information system (1) | Information Technology Officers (1) | Information tool (1) |
| Inhibitor MDM2 (1) | innovation ecosystems (1) | inorganic salts. (1) |
| INR (1) | inß ammation (2) | inß ammatory bowel diseases (1) |
| Insilico anticancer screening (1) | insulin (5) | Insulin receptor (1) |
| Insulin regimen (1) | insulin resistance (1) | Insulin resistance. (1) |
| insulin use in primary care (1) | Insulinophobia (1) | Integrase inhibitor (1) |
| Integrated Courses (1) | integrated economic analysis (1) | Intellectual Property l (1) |
| Intellectual property rights (1) | intelligent tutoring (1) | Intensive care unit (1) |
| Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) | interaction (2) |
| interferon (1) | interleukins (1) | International Collaboration (1) |
| International HIV dementia scale (IHDS) (1) | international organization (1) | international organizations (1) |
| international trade (1) | Internet (1) | interpretation (1) |
| Interventional tool (1) | Intracanal medicament (1) | intraocular presuure (1) |
| Intrauterine Pregnancy (1) | inventory index (1) | inventory management (3) |
| investigators (1) | Invited Article (2) | ion pair complex (1) |
| Ionic gelation (1) | Ionic liquid (3) | Ionic liquid- based microwave-assisted extraction (1) |
| ionic liquid-based microwave-assisted extraction (1) | ionotropic gelation (1) | iontophoresis (2) |
| Iraq (1) | Iridoid glycoside (1) | iron chelation therapy (1) |
| Irvingia gabonensis (1) | isatin (3) | ischemia (1) |
| ischemia-reperfusion injury (1) | Ischemic (1) | ischemic heart disease (1) |
| ISO (1) | isoniazid (2) | isonicotinohydrazide (1) |
| Isopropyl myristate (1) | isoproterenol (1) | isoxazoline (1) |
| itopride HCl (1) | JNC 8 Guidelines. (1) | Journal (1) |
| Jurkat (1) | K+-ATPase β subunit (1) | K+ATP channel (1) |
| K-CAPS (1) | K562 (1) | Kaffir lime (1) |
| Kajjali (1) | Kalanchoe Pinnata (1) | KAP (1) |
| KAP study (1) | Kappa. (1) | Karachi (2) |
| Kathakakhadiradi kashyam (1) | Kati chakrasana (1) | Kernel powder (1) |
| Ketoprofen (1) | Ketorolac (1) | Ketorolac salt (1) |
| Key words: 5-FU (1) | Key words: Esomeprazole (1) | kidney (2) |
| kinetic drug release (1) | Kinetic Modelling (1) | KMnO4 (1) |
| kneading method (1) | kneading technique (1) | knowledge (9) |
| Kochi (1) | Kumar’s score (1) | L-arginine (1) |
| L-Thyroxine (1) | L. acidophilus (1) | labeling (1) |
| Laboratory findings. (1) | Lactobacilli (2) | Lactobacillus (1) |
| Lag period (1) | Lagenaria siceraria (1) | Lantana camara (1) |
| Lantana montevidensis (1) | Larvacidal (1) | LC/MS/MS (1) |
| LC50 (1) | LCMS/MS (1) | LC–MS/MS (1) |
| LDL-C (1) | Leaf (1) | Learning process (1) |
| leaves (4) | Leftover medicines, (1) | Leg Length (1) |
| Leptin (1) | Letter to Editor (4) | Letter to the Editor (3) |
| Letters to the Editor (6) | Leucaena leucocephala (1) | Leucas lavandulaefolia (1) |
| Levocetirizine (1) | Lichen planus (1) | Licofelone (1) |
| Ligand-based drug design (1) | Lightening (1) | Limb Length (1) |
| Limbs (1) | lime fruit (1) | Linoleic acid (1) |
| lipid matrix (1) | lipid metabolism (2) | lipid microspheres (1) |
| Lipid nanocrystals (1) | Lipid peroxidation (3) | lipid peroxides (1) |
| lipid profile (1) | Lipid profile membrane bound enzymes (1) | lipids (1) |
| lipoic acid (1) | liposome (1) | Lippia (1) |
| lithium toxicity (1) | Live-well™ (1) | liver function (2) |
| Liver necrosis (1) | Liver tonic (1) | Liver Transplantation (1) |
| Local drug delivery (1) | locomotor activity (1) | Low-density lipoprotein cholesterol (1) |
| Lozenges (1) | Luffa echinata (1) | Luminesce (1) |
| Lung (1) | Lung cancer (3) | Lupenoic acid (1) |
| Lupus (1) | Lycatab C (1) | lymphadenitis (1) |
| Lysozyme (1) | M. tuberculosis H37Rv (1) | Maceration (1) |
| Macromicroscopy study (1) | Macrophage cell line (1) | Mahkoside A (1) |
| Major Contributed Organizations (1) | Malaysia (4) | Malaysia. (1) |
| Malaysian. (1) | malondialdehyde (2) | Maltodextrin (2) |
| Mammary carcinoma (1) | Mandibular hypoplasia (1) | Mangiferin (1) |
| Mangosteen Peels (1) | manidipine dihydrochloride (1) | Mannich base (1) |
| Mannich Bases (1) | Marine fungi compounds (1) | Mast cell (1) |
| Maternal Care. (1) | matrix (1) | Matrix Tablet (1) |
| matrix tablets (3) | MCF-7 (1) | MDA (2) |
| MDR-TB (2) | mean age (1) | mechanisms (1) |
| Meclizine HCl (1) | Medical (1) | medical costs (1) |
| Medical device (1) | Medical device recalls (1) | medical errors (1) |
| Medical informatics (1) | Medical Inpatients (1) | Medical practitioner (1) |
| Medical Representative (1) | Medical sales representative (1) | Medical students (2) |
| medication adherence (4) | medication adherence behaviour (1) | medication error (2) |
| Medication errors (1) | Medication non-adherence (1) | Medication reconciliation (1) |
| Medication regimen complexity (1) | medication safety (1) | medication-/drug-related problem (MRP/DRP) (1) |
| Medicinal plants (2) | Medicine (2) | medicine-use practices (1) |
| Melanesia (1) | Melastoma malabathricum (1) | Melinjo (2) |
| Meloxicam (1) | Memory (1) | Memory and learning. (1) |
| Men (1) | Menstrual cycle (1) | Mental health (1) |
| Mental health services. (1) | Mentha arvensis (1) | mesalamine (1) |
| Metabolic ratio (1) | Metabolic syndrome (1) | Metabolism (1) |
| Metabolite profiling (1) | Metabomics (1) | metagenomic (1) |
| metformin (7) | metformin hydrochloride (1) | Methanol (1) |
| methanolic extract (1) | methocel (1) | method development (2) |
| method validation (3) | Methotrexate (1) | methyl orange (1) |
| methyl-b cyclodextrin (1) | metoprolol tartarate (1) | MetS (1) |
| Mevalonate (1) | Micro emulsion (2) | Micro particles. (1) |
| Micro-emulsion (1) | microbial contamination (1) | Microbiological (1) |
| Microbroth dilution (1) | Microcapsules (1) | microcrystalline cellulose (5) |
| microdilution (1) | Microdosing (1) | Microencapsules (1) |
| microneedles (1) | Micronucleus assay (1) | microparticles (1) |
| microsphere (1) | Microsphere Phytosome (1) | microspheres (6) |
| microtriches (1) | Microwave assisted extraction (1) | Microwave-Assisted Extraction (2) |
| miglitol (1) | Migraine (2) | migraine management, (1) |
| Mild neurocognitive disorder (1) | Milk (1) | Milnacipran (1) |
| Mimosa pudica (1) | Mineral trioxide aggregate (1) | minimal inhibitory dose (1) |
| Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) | mitochondria (1) |
| Mix mode (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) | Modeling (1) |
| modern medicine (1) | modified melt dispersion technique (1) | Modified Starches (1) |
| Mol inspiration (1) | Molecular characterization (1) | Molecular docking (10) |
| molecular docking and anti cancer activity. (1) | Molecular Docking. (1) | Molecular Dynamic (1) |
| Molecular dynamics (3) | Molecular Dynamics Simulations (1) | Molecular mimicry (1) |
| monoamine oxidase B (1) | Monocots (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | moraceae (1) |
| Morbidity (1) | Morin and validation (1) | Moringa oleifera (2) |
| Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) | Mortality (3) |
| Morus alba (1) | Mosquito repellent (1) | Mouth Dissolving Tablets (1) |
| mouth-dissolving film, (1) | MPTP (1) | MTT Assay (2) |
| MTT method (1) | MUC2 (1) | MUC6 (1) |
| Mucoadhesive (1) | Mucoadhesive agent (1) | mucoadhesive formulation (1) |
| Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) | mucodhesive (1) |
| multi granules (1) | multidrug resistant pathogens (1) | Multikinase Inhibitor (1) |
| multiparticulates (1) | multiparticulates dosage form (1) | multiple regression (1) |
| multiple regression analysis (1) | Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) |
| Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (1) | Mycophenolic acid (1) |
| myocardial infarction (1) | Myomectomy. (1) | Myrica esculenta (1) |
| Myristicin (1) | N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) |
| Na+/K+-Atpase (1) | NABP (1) | NACO. (1) |
| Nadi shuddhi pranayama (1) | Naftopidil (1) | nano size (1) |
| Nanoemulsion (1) | Nanoformulation (2) | nanoformulations (1) |
| Nanonization. (1) | Nanopacticle (1) | Nanoparticle (1) |
| Nanoparticles (9) | Nanosuspension (1) | Nanosuspension tablets (1) |
| Nanosuspensions (1) | Naphthoquinone derivative (1) | NAPLEX (1) |
| naproxen (1) | Naranjo (1) | Naranjo algorithm (2) |
| Naranjo algorithm. (1) | Naranjo’s ADR probability scale (1) | Narikel Lavan (1) |
| Narrow therapeutic index drugs (1) | Nasal gel (1) | Nateglinide (1) |
| National Fomulary (1) | National Formulary (2) | National Public Health Programs (1) |
| Natural (1) | natural compounds (3) | Natural Polymers (1) |
| natural products (2) | NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) |
| nebivolol hydrochloride (1) | Necrosis. (1) | need assessment (1) |
| Nephroprotective (3) | Nephrotic syndrome (1) | Nephrotoxicity (1) |
| Nerium indicum (1) | neuropathy (1) | Neurosurgical (1) |
| neutropenia (1) | nevirapine (1) | new molecule (1) |
| Newborns (1) | Nicorandil (1) | Nicotine (1) |
| Nicotine dependence (1) | Nifedipine. (1) | Nigeria. (1) |
| nigrostriatal pathway (1) | Nil (8) | Nill (18) |
| niosome (1) | Niosomes (1) | Nitric acid (1) |
| Nitric oxide (2) | Nitrogen starvation (1) | NMDA (1) |
| NMDA receptors (1) | Nodular skin lesions (1) | Non-linear (1) |
| non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) | Non-steroidal anti-inflammatory drugs (1) |
| Non-surgical endodontic therapy (1) | nonamers. (1) | noncommunicable disease (1) |
| noncompliance (1) | Nonionic surfactants (1) | nootropic (1) |
| Norfloxacin (1) | Normoglycemic rats (1) | northeast India (1) |
| Nose to brain delivery (1) | Nothopanax scutellarium (1) | Nuclear medicine (1) |
| nuclear pharmacy (1) | Nucleo CMP (1) | Nude mice (1) |
| Nutmeg oil (1) | Nutraceuticals (1) | Nutrient starvation (1) |
| Nutrition (1) | Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) |
| Obesity (2) | Occupational health (1) | Ocimum gratissimum (1) |
| Off-label (1) | offending drugs (1) | Okra Mucilage (1) |
| Olmesartan (1) | olmesartan medoxomil (1) | Omega-6 fatty acid (1) |
| Omeprazole. (1) | Omics (1) | Oncology. (1) |
| ondansetron (3) | ondansetron hydrochloride (1) | OPD – Outpatient Department. (1) |
| open field (1) | Ophthalmic (1) | ophthalmic delivery (1) |
| ophthalmic inserts (1) | Opportunities (1) | Optimal stress (1) |
| optimization (7) | Oral bacteria (1) | Oral cancer (2) |
| oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
| Oral hypoglycemic drugs (1) | oral insulin (1) | Oral Rehabilitation (1) |
| Organ Toxicities (1) | organic acids (1) | organogel (1) |
| Organophosphate (1) | Origanum vulgare (1) | Original Article (3) |
| Originator. (1) | Orlistat (1) | orodispersible tablet (1) |
| orodispersible tablets (2) | Osmotic pump (1) | Osteoarthritis (1) |
| Osteoblast (2) | Osteoclast (1) | OTC switch (1) |
| Otomycosis (2) | Outdoor patients (1) | Outpatients (1) |
| ovalbumin (1) | Ovarian (1) | Over-the-counter (1) |
| Overweight (1) | OVX (1) | oxazepinone (1) |
| oxcarbazepine (1) | oxidative damage (1) | oxidative stress (6) |
| Oxyresveratrol (1) | oxytetracycline (1) | P-dimethylaminobenzaldeyde (1) |
| P-drug. (1) | P-drugs (1) | P-glycoprotein (1) |
| P. dulce (Fabaceae) (1) | p53 tumor suppressor gene (1) | Package insert (1) |
| Paediatric (2) | Pain (2) | Pain. (1) |
| Painkiller (1) | pair wise procedures (1) | Pakistan (2) |
| Pakistan. (4) | Paliperidone palmitate (1) | Pancreatitis. (1) |
| Pantoprazole (1) | papain (1) | Papain. (1) |
| PAR-2 receptor (1) | para-diaminobenzaldehyde (1) | paracetamol (2) |
| Paracetamol. (2) | Parkinson’s disease (1) | partial least square (1) |
| particle size analysis (1) | PASS (1) | passive avoidance learning (1) |
| Patch (1) | patents (2) | Pathological response (1) |
| Patient (2) | Patient adherence. (1) | patient counseling (1) |
| Patient counseling and Patient information leaflet (1) | patient education (1) | Patient health questionnaire (PHQ) (1) |
| Patient satisfaction (1) | Patient Survival (1) | patient-physician communication (1) |
| Patient-safety (1) | patients (2) | Patients. (1) |
| paw edema (1) | Paw edema. (1) | Paw volume (1) |
| PE 18:0/18:0-PEG 2000 (1) | Pectin (1) | pedagogy (1) |
| Pediatric (2) | Pediatric cancer (1) | Pediculosis (1) |
| Pegagan extract (1) | PEGylation (1) | Pemphigus vulgaris (1) |
| Penang (1) | penetration (3) | penetration enhancer (1) |
| penetration pressure (1) | penicillamine (1) | Penicillins (1) |
| pentylenetetrazole (1) | PEO (1) | Peperomia pellucida (L) Kunth (1) |
| Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) | Peptic Ulcer. (1) |
| peptide vaccine (1) | Peptidoglycan (1) | percentage healing of wound area (1) |
| perception (3) | Periauricular tags. (1) | pericyclic fiber (1) |
| Periodontal disease (1) | periodontal diseases (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permeation (2) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) |
| Persistent ulcer (1) | Personal care products (2) | pH dependent approach (1) |
| pH independence (1) | pH-sensitive (1) | Phaleria marcocarpha (1) |
| Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) | pharma counseling (1) |
| pharmaceutical (1) | pharmaceutical advertisements (1) | Pharmaceutical care (2) |
| pharmaceutical care. (1) | pharmaceutical formulations (1) | Pharmaceutical Marketing (1) |
| Pharmaceutical Services (1) | Pharmaceutical-Care (1) | Pharmaceutical-industries (1) |
| Pharmacist (4) | Pharmacist intervention. (1) | pharmacist role in public health (1) |
| Pharmacists (1) | pharmacists India (1) | Pharmacodynamic (2) |
| Pharmacodynamic activity (1) | pharmacodynamics (2) | Pharmacogenetics (1) |
| Pharmacogenomics (1) | pharmacognostic standardization (1) | pharmacognostical (1) |
| pharmacognosy study (1) | Pharmacokinetic (4) | Pharmacokinetic interactions. (1) |
| pharmacokinetics (8) | Pharmacokinetics. (2) | Pharmacological properties (1) |
| Pharmacophore (3) | Pharmacovigilance (13) | Pharmacovigilance Programme of India (1) |
| Pharmacovigilance. (1) | Pharmacovigilante’s (1) | pharmacy (5) |
| pharmacy curriculum (2) | Pharmacy education (1) | Pharmacy Enforcement Division (1) |
| Pharmacy informatics (1) | Pharmacy services (1) | Phase diagrams (1) |
| Phase I studies (1) | Phase rule (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | Phenolic (1) |
| phenolic compounds (2) | phenolics (1) | phenols (1) |
| Phenothiazine (1) | Phenytoin (1) | Phenytoin cold cream (1) |
| Pheritima posthuma (1) | Phleboliths (1) | Phoenix dactylifera (1) |
| Phosphorylase kinase (1) | Photoprotection. (2) | Phthalates (1) |
| Phyllanthus emblica, (1) | Phylogenetic tree (1) | Physical fitness (1) |
| Physical stability (1) | Physichochemical Characterization (1) | Physicians (3) |
| physicochemical evaluation (1) | physicochemical properties (1) | physiochemical descriptor (1) |
| Physiological role (1) | Phytochemical (2) | phytochemical prospection (1) |
| Phytochemical screening (1) | Phytosome (1) | picrotoxin (1) |
| pictograms (1) | Pilgrims (1) | PIM (1) |
| Pinus merkusii (1) | pioglitazone (1) | piperazine citrate (1) |
| Piperine (1) | Piroxicam (1) | Pits and Fissures (1) |
| Pixel intensity. (1) | Plackett-Burman (1) | Plackett-Burman design (1) |
| plant extracts (1) | plasma (3) | Plasma concentration (1) |
| plasma concentrations (1) | Plasma creatinine (1) | Plasma insulin (1) |
| Plasma urea (1) | plasma-brain correlation (1) | Plasma. (1) |
| Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) | Platelet aggregation. (1) |
| Platelet rich fibrin membrane. (1) | Pleiotropic effects (1) | PLGA (1) |
| PLSR (1) | Pluronic F 127 (1) | Pneumonia (1) |
| Poison (2) | Poisoning pattern (1) | Polarography (1) |
| Poloxamer 188 (1) | Poloxamer 407 (2) | Poloxamer 407. (1) |
| poly (lactic-co-glycolic acid) (1) | Poly herbal (1) | poly(ε-caprolactone) (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymeric nanoparticles (2) | polypharmacy (6) |
| polypharmacy in diabetes mellitus. (1) | polyphenols (1) | Polysaccharide (1) |
| polyvinyl alcohol (2) | polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) |
| Polyvynil pyrrolidone (1) | porosity (1) | Port-A Catheter. (1) |
| Positive and Negative stressors (1) | Positive coping strategies. (1) | Posology (1) |
| Possible mechanisms (1) | Posterior reversible encephalopathy syndrome (1) | Potassium (1) |
| Potassium Channel (1) | Potassium chloride (1) | Potassium Nitrate (1) |
| PPAR agonists (1) | PPARγ agonists. (1) | PPBG (1) |
| pPharmacokinetics (1) | PPP model (1) | practice (3) |
| practices (1) | pravastatin (1) | Pre ADMET (1) |
| pre prandial (1) | Pre University students (1) | Pre-authorization (1) |
| Prebiotic (2) | Precipitation (1) | precise (1) |
| Precision (1) | Predictors (1) | Pregabalin (1) |
| Pregnancy (2) | preliminary screening (1) | Premna esculenta (1) |
| prescriber (1) | Prescribing (1) | Prescribing errors (1) |
| Prescribing pattern. (1) | Prescription (3) | Prescription error. (1) |
| prescription monitoring (1) | prescription only medicines (1) | Prescription pattern (1) |
| Prescription review (1) | pressure dependent approach (1) | Prevalence (3) |
| Primary health care (2) | Primary Health Care. (1) | Principal component analysis (1) |
| principal component regression (1) | Pristane (1) | Private Medical College (1) |
| PRO (1) | Probable (1) | Probiotic (1) |
| Probiotics (1) | Problem-based learning (1) | process capability (1) |
| Process parameters. (1) | Products with Antimicrobial Action. (1) | progesterone (1) |
| Proniosomal gel (1) | propolis (1) | Proportional reporting ratio (1) |
| propranol hydrochloride (1) | Propranolol hydrochloride (1) | Prospective Study (2) |
| prostaglandins (1) | Proteasome activity (1) | protein proÞ le (1) |
| proteolytic enzymes (1) | Proton adduct (1) | Proton Pump Inhibitor (2) |
| Proton-pump Inhibitors (1) | Protransfersome (1) | Prteomics (1) |
| Pseudo ternary phase diagrams (1) | Pseudomonas aeruginosa (1) | Psidium Guajava (1) |
| Psychological mindedness (1) | Psychomotor (1) | Psychosis (2) |
| Psychotropic drugs (1) | Psychotropics (1) | Pterocarpus indicus (1) |
| Pterocarpus indicus Willd (1) | Public health hospital (1) | Publication (1) |
| Publications (2) | Pulmonary Fibrosis (1) | pulmonary hypertension (1) |
| Punica granatum (1) | pyrazine (1) | pyrazoline (1) |
| pyrazolines (1) | Pyrimidine (1) | Q1F (1) |
| QOL (1) | QSAR (2) | qualitative (1) |
| Qualitative analysis (1) | qualitative study (1) | Quality (1) |
| quality assurance (1) | Quality Control (1) | Quality Indicators (1) |
| quality of internet information (1) | quality of life (4) | quantitative structure-activity relationship (1) |
| Quercetin (2) | quinazolin-4(3H)one (1) | quinazolinone (1) |
| Quinazolinone. (1) | quinoline derivatives (1) | R2 values (1) |
| Rabbits. (1) | radical scavenger (1) | radicals (1) |
| radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
| Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raman spectroscopy (2) |
| ramipril (2) | ranitidine (1) | Ranitidine hydrochloride (2) |
| Ranitidine’. (1) | ranolazine (1) | Ransmission electron microscopy (1) |
| Rapid disintegration (1) | Rasagiline mesylate (1) | Rat (1) |
| ratio test procedures (1) | Rational pharmacotherapy. (1) | Rational prescribing (1) |
| Rational use of medicine (1) | rational use of medicines (1) | rats (1) |
| Rattus novergicus (1) | re-precipitation (1) | recognized standards (1) |
| recovery studies (1) | Red ginger (1) | Reflective pedagogy paradigm (1) |
| reforms (1) | Regeneration (1) | Regression analysis (1) |
| Regressions statistics (1) | Regulation (1) | Regulations (1) |
| regulatory (2) | Regulatory affairs (1) | regulatory system (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| research (1) | Research Skills. (1) | reserpine (1) |
| Resident doctors (1) | Resistance (3) | Resistant starch (1) |
| Respiratory tract (1) | Response Surface Methodology (1) | Response surface methodology. (1) |
| Response to antiretroviral therapy (1) | Resveratrol (2) | retail pharmacy (1) |
| Retention. (1) | retrospective cohort (1) | Retrospective study (1) |
| reversed-phase chromatography (1) | Rhabdomyolysis (1) | Rhaphidophora pinnata (1) |
| rhizomes (1) | Riboflavin (1) | Rice Bran Oil (1) |
| Rifampicin (1) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
| Riociguat (1) | Risk factor. (1) | Risk factors (1) |
| Risk Factors. (1) | Rituximab. (1) | rivastigmine (1) |
| RNAi (1) | RNAi technology (1) | RNTCP (1) |
| Rodenticides (1) | root (1) | Root canal infection (1) |
| Roots extract (1) | Ropinirole (1) | rosuvastatin (2) |
| rosuvastatin calcium (1) | Royal Malaysian Custom Officer (1) | RP-HPLC (5) |
| RP-HPLC method (1) | RP-TLC/Densitometry (1) | Rubus fraxinifolius (1) |
| Rubus rosifolius (1) | rupatadine (1) | rutin (1) |
| ß avonoids (2) | S. mutans (1) | S.salivarius (1) |
| S.sanguis (1) | Saccharin (1) | Safe handling guidelines (1) |
| Safety (1) | Sage (1) | Saponin (1) |
| saponins (1) | Sappan wood (1) | Saraschandra (1) |
| Saudi Arabia (1) | Saussurea lappa (1) | scanning electron microscopy (3) |
| Scientific Advertisements (1) | Scientometrics (3) | sclerotherapy (1) |
| Scores. (1) | Se- DeM ODT Expert system (1) | Second-line agents (1) |
| Secondary Level (1) | seizure outcome (1) | Seizures (1) |
| Selected area electron diffraction (1) | Self medication (1) | self-emulsifying drug delivery system (1) |
| Self-Harm (1) | self-medication (5) | self-nanoemulsification (1) |
| Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
| sensory cortical activity. (1) | separation (1) | sepbox (1) |
| Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
| Serum (1) | Serum Glutamate-Pyruvate Transaminase (1) | Serum Glutamic Oxaloacetic Transaminase (1) |
| Serum triglyceride (1) | Serum. (1) | sesame oil (1) |
| severe febrile neutropenia (1) | Severe sepsis (1) | Severity (1) |
| Sexual dysfunction in diabetes (1) | Shodhana (1) | Short Communication (3) |
| short-term memory (1) | Sida rhomboidea.Roxb (1) | Side effect (1) |
| signal detection (1) | Signal detection. (1) | silymarin (1) |
| similarity factor (f2) (2) | simplex lattice (1) | Simplex Lattice Design (2) |
| simultaneous determination (2) | simultaneous extraction (1) | simvastatin (1) |
| simvastatin. (1) | Single nucleotide polymorphism (1) | sintering (1) |
| siRNA (1) | siRNA. (2) | SIRT1 (1) |
| Sirtuin (1) | six sigma (1) | SJS (1) |
| SLS (1) | Smix. (1) | Smoking (1) |
| smoking cessation. (1) | Smoking. (1) | smooth muscle cells (1) |
| Snake bite (1) | SNEDDS (2) | sobatum (1) |
| Social Media (1) | Social sexual. (1) | SOD (1) |
| Sodium (1) | sodium alginate (1) | sodium alginate. (2) |
| sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) | Sodium starch glycolate (SSG) (1) |
| Solanum nigrum (1) | Solanum trilobatum (1) | Solanum viarum (1) |
| Solanum xanthocarpum, (1) | solid dispersion (5) | solid lipid nanoparticles (1) |
| Solid lipid nanoparticles. (1) | solubility (5) | Solubility enhancement (1) |
| Solubility. (1) | solvent casting (1) | solvent evaporation (3) |
| Solvent evaporation. (1) | sonication time (1) | sonophoresis (1) |
| Sorafenib (1) | Spacedrepetition. (1) | spasmolytic (1) |
| speciÞ city (1) | Spectrometric (1) | spectrophotometry (2) |
| sperm count (2) | SPF (1) | Spiro compounds (1) |
| Spleen colony assay (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| SPSS 20. (1) | ST segment elevation (1) | stability (1) |
| stability indicating (1) | stability indicating and validation. (1) | Stability indicating assay (1) |
| Stability indicating assay method (1) | stability indicating method of artemether (1) | stability indicating. (1) |
| Stability of the physical properties (1) | Stability test (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (4) |
| Staphylococcus aureus (1) | Starlac (1) | Statin pathway (1) |
| Statins. (1) | Statistical Modeling (1) | Statistical optimization (1) |
| Stelechocarpus burahol (1) | Stem bark extract (1) | Stephania hernandifolia (1) |
| Stereospermum suaveolens (1) | Stereospermum tetragonum (2) | Sterilization Procedures (1) |
| Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) | Stilbene (1) |
| Stimulantia (1) | Stimuli (1) | Stomatitis under prosthesis (1) |
| Streptococci (1) | Streptococcus mutans (2) | Streptokinase (1) |
| Streptomonospora arabica (1) | Streptomyces (1) | Streptozotocin (2) |
| Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) | Streptozotocin. (1) |
| stress (3) | stress studies (2) | stroke and cardiac pacemaker. (1) |
| Stroke prevention (1) | structural descriptor (1) | Structured Communication. (1) |
| Stryphnodendron rotundifolium (1) | students (3) | students’ residence (1) |
| Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) | Subcutaneous fat (1) |
| sublingual films (1) | substituted acetophenones (1) | sucrase (1) |
| Sudan (1) | Sulfonylurea (2) | Sulfonylureas (1) |
| Sulphorhodamine-B (1) | Sun (1) | sun protection factor (2) |
| Sunlight (1) | Sunscreens. (1) | Super disintegrants (1) |
| superdisintegrants (2) | Superdisintergrants (1) | Superoxide Dismutase. (1) |
| superoxidedismutase (1) | superporous hydrogel composite (1) | Supply Chain Management (1) |
| support staff. (1) | Surface properties (1) | surfactant (1) |
| surfactants (1) | surgical prophylaxis. (1) | Surgical. (1) |
| Survey questionnaire (1) | survey. (1) | Survival rate (1) |
| sustained release (3) | sustained release pellets (1) | sustained release. (1) |
| Sweet orange peel extract (Citrus sinensis) (1) | swelling index (1) | swelling studies (1) |
| Symptoms (1) | Synchronous spectrofluorimetry. (1) | Synergism. (1) |
| Synthesis (2) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) | Systematic Review. (1) |
| Systemic steroids. (1) | Systems biotechnology (1) | Systolic dysfunction. (1) |
| T cell epitope (1) | T regs (1) | Tab. Pardopa (1) |
| Tablet Compression (1) | Tacrolimus (1) | Tacrolimus Once Daily (1) |
| Tacrolimus Twice Daily. (1) | Tactile stimulation (1) | tail suspension test (1) |
| Tamarindus indica (1) | Tamilians (1) | Tamoxifen (1) |
| Target delivery (1) | Targeted drug delivery system (1) | taste masking (2) |
| tasteless complex (1) | taxane (1) | Taxus baccata (1) |
| Teaching Hospital (1) | Technology (1) | technology-enhanced learning (1) |
| tegument (1) | telmisartan (1) | TEN (1) |
| Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) | Terminalia bellirica (1) |
| Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | Ternary phase diagram (1) | terpenoids (1) |
| Tertiary Care (1) | Tertiary care hospital (2) | testicular damage (1) |
| testosterone (3) | Tetrapreniltoluquinone (1) | thalassemia major (1) |
| therapeutic angiogenesis (1) | therapeutic dose (1) | therapeutic drug monitoring (1) |
| therapeutic effectiveness (1) | Thermoreversible gel (1) | Thixogel (1) |
| Three component system (1) | thrombocytopenia (1) | Thrombolysed subjects (1) |
| Thrombolytic (1) | thrombolytic enzymes (1) | Thyme oleoresin (1) |
| Thyrotoxicosis. (1) | time dependent approach (1) | Time lag (1) |
| Timed release (1) | Tobacco (2) | Tobacco smoking (1) |
| tolbutamide (1) | Tolerance (1) | Tooth brush. (1) |
| Toothpaste. (1) | Topical delivery. (1) | Topical. (1) |
| Total flavonoid (1) | Total flavonoid content (2) | Total phenolic (2) |
| Total phenolic content (1) | total polyphenolic content (1) | total quality management (1) |
| toxicity (3) | Toxicity. (2) | traditional medicine (2) |
| Training of Central sterile and supply department employees (1) | tramadol HCL (1) | Tramadol Hydrochloride (1) |
| Trans-cinnamic acid (1) | Trans-resveratrol (1) | Transcriptomics. (1) |
| transdermal (2) | transfer latency (1) | Transfersome (2) |
| Transfersomes. (1) | Translation (1) | Transmucosal (1) |
| Transmucosal patch (1) | Trauma induced external inflammatory root resorption (1) | Treatment adherence. (1) |
| Treatment outcomes (1) | Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) |
| Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) | Triglycerides (1) |
| Trigonella foenum graecum (1) | Trigonelline (1) | Trinidad & Tobago (1) |
| trinitrobenzene sulfonic acid (1) | Triphala (1) | triple distilled water (1) |
| Triterpenoid. (1) | Triterpenoids (1) | Triticum aestivum. (1) |
| Tropaeolum majus L (1) | tropicamide (1) | Troponin-I (1) |
| Trypsin (1) | TSLP (1) | Tuberculosis (3) |
| Tuberculosis/HIV (1) | Tumor response (1) | Tween 80. (1) |
| Twisted (1) | Tylophora indica (1) | Tylophorinidine. (1) |
| type 2 diabetes (2) | Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) |
| UACR (1) | UCPMP Guidelines (1) | ultrasonication-solvent evaporation technique (1) |
| Unani medicine (1) | Uncemented (1) | Underutilization of insulin. (1) |
| Unethical practices. (1) | Unique device identification (1) | Universities (1) |
| Unlicensed. (1) | Unnecessary use. (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) |
| Urban area (1) | urea (1) | Urinary Hydrogen Peroxide (1) |
| Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) | Urine volume (1) |
| urolithiasis (1) | Urtica dioica L (1) | Usefulness. (1) |
| Uterine fibroid (1) | Uterine Perforation. (1) | UV derivative spectrophotometry (1) |
| UV detection (2) | UV Spectrophotometric method (1) | UV spectrophotometry (1) |
| UV-spectrophotometric method (1) | UV-spectrophotometry (2) | Vaccine (1) |
| Vaccine design (1) | vada (1) | vaginal gel (1) |
| Vaginitis. (1) | Vakrasana (1) | validation (15) |
| Valium (1) | Valproate (1) | valsartan (1) |
| Vanillin (1) | Vanillosmopsis arborea. (1) | vascular bundle (1) |
| vascular permeability (2) | vascular progenitors (1) | VED analysis (2) |
| VED analysis. (2) | VEGFR-2 (1) | Venetoclax (1) |
| Venography and Hemangioma (1) | Venous malformations (VMs) (1) | verapamil (3) |
| Verapamil HCl (1) | Vincristine. (1) | Vinegar (1) |
| Virtual Screening (1) | Viscosity (1) | visible Spectrophotometry (1) |
| visible spectroscopy (1) | Visual analogue scale. (1) | Vitamin D (2) |
| Vitamin D deficiency (1) | Vitamin D. (1) | vitamin E (1) |
| vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) | Vitex agnus Castus (1) |
| Voltage–gated calcium channels (1) | warfarin (2) | Warning signs (1) |
| Water hyacinth (2) | web-based learning (1) | Weibull parameters (1) |
| West timor (1) | Western blot technique (1) | Wet gangrene (1) |
| wet granulation (1) | wetting time (1) | Wheat (1) |
| White/red patch (1) | WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) |
| Wilson disease (1) | Wistar rats. (1) | Withania somnifera. (1) |
| Withdrawal (1) | Women. (1) | Work protection (1) |
| Wound Healing (1) | Wrightia tinctoria (1) | writhing (1) |
| X-ray diffraction (1) | X-ray imaging study. (1) | X-ray powder diffraction (1) |
| xanthan gum (1) | Xanthangum (1) | XDR-TB (1) |
| Xenografts (1) | Xenografts. (1) | XRD (1) |
| Ylang-ylang (1) | Yoga (1) | Yucca gloriosa L. (1) |
| Zea m1 pollen allergen (1) | Zero order release (1) | zero order spectrophotometry (1) |
| zeta potential (1) | zidovudine (1) | Zika virus (1) |
| zinc (1) | Zinc ion (1) | Zingiber officinale (1) |
| Zingiberaceae (1) | zopiclone (1) | [BMIM]PF6 (1) |
| Þ rst-order derivative spectroscopy (1) | Α-amylase (2) | α-glucosidase (1) |
| α-mangostin (1) | β Amyloid1-42 (1) | β-carboline (1) |
| β-carotene production (1) | β-cyclodextrin (2) | γ-oryzanol (1) |
| ε-amino groups (1) | | |
